Delivery Order SPE2DB20D3101-SPE2DB25FRRB7
Award Date 7/28/25
Potential Completion Date 8/18/25
Potential Value $11K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Tagrisso 80 mg tablets (30-count units) with a ceiling value of $31,987.71. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 18, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, indicating that AmerisourceBergen Drug Corp...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Tagrisso 80 mg tablets (30-count units) under a firm fixed-price contract with a ceiling value of $10,662.57. The contract, which carries no set-aside designation, is a competitively awarded delivery order with an ultimate completion date of August 18, 2025. This award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency (DLA) awarded a $21,325.14 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Tagrisso 80 mg tablets (30-count units) with an ultimate completion date of August 14, 2025. This non-set-aside contract was competitively awarded on July 24, 2025, with performance occurring at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Tagrisso 80 mg tablets (30-count) valued at $21,325.14. This firm fixed-price delivery order, with an ultimate completion date of August 11, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was made through open competition with no set-aside designation, and the place of performance is...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on July 21, 2025, for the supply of Tagrisso 80 mg tablets in quantities of 30, with a ceiling value of $10,662.57. This is a firm fixed-price delivery order with an ultimate completion date of August 11, 2025, and represents fulfillment of pharmaceutical needs for military and federal healthcare systems. The contract carries no set-aside designation, indicating it was competitively awarded....
- The Defense Logistics Agency awarded a delivery order valued at $31,987.71 to AmerisourceBergen Drug Corp for the supply of Tagrisso 80 mg tablets (30-count units) on July 23, 2025, with an ultimate completion date of August 13, 2025. This firm fixed-price delivery order was awarded without a set-aside designation through open competition, reflecting the contractor's capability to meet federal procurement standards. The contract will be performed at AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at approximately $32,000 to AmerisourceBergen Drug Corp for the supply of Tagrisso 80 mg tablets (30-count units) on July 25, 2025, with an ultimate completion date of August 15, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal vendor specializing in...
- The Defense Logistics Agency (DLA) awarded a $21,325.14 delivery order to AmerisourceBergen Drug Corp for 30 tablets of Tagrisso 80 mg, a prescription oncology medication used in cancer treatment. The contract, awarded on July 31, 2025, with an ultimate completion date of August 21, 2025, utilizes firm fixed price pricing with no set-aside designation, indicating the award was competitively procured. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken,...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $10,538.79 to Amerisourcebergen Drug Corporation for the supply of Tagrisso 80 mg tablets. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, worth up to $999,999,999.00 through December 2025. Under this IDC, Amerisourcebergen provides a comprehensive range of pharmaceutical products and medical supplies, including specialty,...
- The Defense Logistics Agency awarded a delivery order valued at $10,662.57 to AmerisourceBergen Drug Corp for the supply of TAGRISSO 80 mg tablets (30-count packaging) on July 29, 2025, with an ultimate completion date of August 19, 2025. The contract employs firm fixed-price pricing and was not issued under any set-aside designation, indicating competitive award through open competition. Performance of this delivery order is based at AmerisourceBergen's corporate office location in...